Sabrina Strobel, Jeswinder Sian-Hulsmann, Dennis Tappe, Kurt Jellinger, Peter Riederer, Camelia-Maria Monoranu
{"title":"Postencephalitic Parkinsonism: Unique Pathological and Clinical Features—Preliminary Data","authors":"Sabrina Strobel, Jeswinder Sian-Hulsmann, Dennis Tappe, Kurt Jellinger, Peter Riederer, Camelia-Maria Monoranu","doi":"10.3390/cells13181511","DOIUrl":null,"url":null,"abstract":"Postencephalitic parkinsonism (PEP) is suggested to show a virus-induced pathology, which is different from classical idiopathic Parkinson’s disease (PD) as there is no α-synuclein/Lewy body pathology. However, PEP shows a typical clinical representation of motor disturbances. In addition, compared to PD, there is no iron-induced pathology. The aim of this preliminary study was to compare PEP with PD regarding iron-induced pathology, using histochemistry methods on paraffin-embedded post-mortem brain tissue. In the PEP group, iron was not seen, except for one case with sparse perivascular depositions. Rather, PEP offers a pathology related to tau-protein/neurofibrillary tangles, with mild to moderate memory deficits only. It is assumed that this virus-induced pathology is due to immunological dysfunctions causing (neuro)inflammation-induced neuronal network disturbances as events that trigger clinical parkinsonism. The absence of iron deposits implies that PEP cannot be treated with iron chelators. The therapy with L-Dopa is also not an option, as L-Dopa only leads to an initial slight improvement in symptoms in isolated cases.","PeriodicalId":9743,"journal":{"name":"Cells","volume":null,"pages":null},"PeriodicalIF":5.1000,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cells","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.3390/cells13181511","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Postencephalitic parkinsonism (PEP) is suggested to show a virus-induced pathology, which is different from classical idiopathic Parkinson’s disease (PD) as there is no α-synuclein/Lewy body pathology. However, PEP shows a typical clinical representation of motor disturbances. In addition, compared to PD, there is no iron-induced pathology. The aim of this preliminary study was to compare PEP with PD regarding iron-induced pathology, using histochemistry methods on paraffin-embedded post-mortem brain tissue. In the PEP group, iron was not seen, except for one case with sparse perivascular depositions. Rather, PEP offers a pathology related to tau-protein/neurofibrillary tangles, with mild to moderate memory deficits only. It is assumed that this virus-induced pathology is due to immunological dysfunctions causing (neuro)inflammation-induced neuronal network disturbances as events that trigger clinical parkinsonism. The absence of iron deposits implies that PEP cannot be treated with iron chelators. The therapy with L-Dopa is also not an option, as L-Dopa only leads to an initial slight improvement in symptoms in isolated cases.
脑后帕金森病(PEP)被认为是一种由病毒引起的病理现象,它不同于传统的特发性帕金森病(PD),因为它没有α-突触核蛋白/刘易斯体病理现象。然而,帕金森病患者表现出典型的运动障碍临床表现。此外,与帕金森病相比,该病没有铁诱导的病理变化。这项初步研究的目的是,通过对石蜡包埋的尸检脑组织进行组织化学分析,比较 PEP 和 PD 在铁诱导病理方面的差异。在 PEP 组中,除一例有稀疏的血管周围沉积外,未见铁。相反,PEP 提供了一种与 tau 蛋白/神经纤维缠结有关的病理学,仅有轻度至中度记忆障碍。据推测,这种由病毒引起的病理变化是由于免疫功能失调导致(神经)炎症引起的神经元网络紊乱,从而引发临床帕金森病。没有铁沉积意味着不能使用铁螯合剂治疗帕金森病。使用左旋多巴治疗也不是一种选择,因为左旋多巴只能在个别病例中使症状得到初步的轻微改善。
CellsBiochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)
CiteScore
9.90
自引率
5.00%
发文量
3472
审稿时长
16 days
期刊介绍:
Cells (ISSN 2073-4409) is an international, peer-reviewed open access journal which provides an advanced forum for studies related to cell biology, molecular biology and biophysics. It publishes reviews, research articles, communications and technical notes. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the length of the papers. Full experimental and/or methodical details must be provided.